Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 16

    Ban on online sale of medicines: Delhi HC issues notice to Centre, e-pharmacies on contempt plea

    Ban on online sale of medicines: Delhi HC issues notice to Centre, e-pharmacies on contempt plea

    Meghna A Singhania25 April 2019 2:21 PM IST
    The council claimed that the e-pharmacies in willful disobedience of the order passed by the high court are selling medicines online.New Delhi: The...
    Now State Drug Controllers to have authority to issue STOP SALE order of Medicines: CDSCO to amend to rule

    Now State Drug Controllers to have authority to issue STOP SALE order of Medicines: CDSCO to amend to rule

    Meghna A Singhania23 April 2019 12:20 PM IST
    New Delhi: Empowering State Drug Controllers, the Government will soon amend Rule 66 of Drugs and Cosmetics (D&C) Rules, 1940 thereby granting...
    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Meghna A Singhania21 April 2019 2:26 PM IST
    The exemption from obtaining a licence for Form 29 is subject to the condition that the information about the manufacturing of approved drugs for...
    Chemists and Druggists or Pharmacy? DTAB decides on nomenclature

    Chemists and Druggists or Pharmacy? DTAB decides on nomenclature

    Meghna A Singhania20 April 2019 11:44 AM IST
    New Delhi: The highest statutory decision-making body under CDSCO, Drug Technical Advisory Board (DTAB) has given its in principal nod to replace the...
    Mandatory QR coding for APIs soon: DTAB

    Mandatory QR coding for APIs soon: DTAB

    Meghna A Singhania19 April 2019 11:21 AM IST
    New Delhi: Drugs Technical Advisory Board (DTAB), functional under the Central Drugs and Standard (CDSCO) has recommended “making it mandatory to have...
    Government to revise limit of free salicylic acid content in drugs containing ASPIRIN

    Government to revise limit of free salicylic acid content in drugs containing ASPIRIN

    Meghna A Singhania18 April 2019 3:13 PM IST
    New Delhi: Government is soon going to revise the limit of free salicylic acid content in medicines containing Aspirin, as the Drugs and Techincal...
    All medical devices sold in India to be CDSCO certified: What is Means

    All medical devices sold in India to be CDSCO certified: What is Means

    Meghna A Singhania18 April 2019 2:59 PM IST
    Once this notification comes into effect, the manufacture and sale of all medical devices would have to be certified by the Central Drugs Standard...
    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Garima18 April 2019 10:15 AM IST
    If the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), under the Ministry of AYUSH goes through the proceeds, would add to...
    Adverse Reactions: Cefotaxime, Oflaxicin, Cefixime told to carry Warning by CDSCO

    Adverse Reactions: Cefotaxime, Oflaxicin, Cefixime told to carry Warning by CDSCO

    Meghna A Singhania17 April 2019 12:26 PM IST
    New Delhi: The national regulatory body for Indian Pharmaceutical and Medical Device, Central Drugs Standard Control Organisation (CDSCO) has ordered...
    CDSCO expert committee suggests ban of yet another 324 FDCs

    CDSCO expert committee suggests ban of yet another 324 FDCs

    Meghna A Singhania15 April 2019 11:49 AM IST
    New Delhi: Domestic drugmakers are likely to face a blow as 324 Fixed Dose Combination (FDCs) drugs have been recommended to be banned by an expert...
    Upload application in SUGAM as per new Rules: CDSCO issues notice

    Upload application in SUGAM as per new Rules: CDSCO issues notice

    Meghna A Singhania13 April 2019 1:39 PM IST
    New Delhi: Through a recent notice, the Central Drugs Standard Control Organization (CDSCO) has informed that uploading of applications through SUGAM...
    Ethical Guidelines mandatory for any Biomedical Research in India: ICMR

    Ethical Guidelines mandatory for any Biomedical Research in India: ICMR

    Meghna A Singhania9 April 2019 9:32 AM IST
    New Delhi: Indian Council of Medical Research’s (ICMR) National Ethical Guidelines for Biomedical Research has become mandatory and needs to be...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    NPPA fixes prices of 29 formulations under DPCO, check out details

    NPPA fixes prices of 29 formulations under DPCO, check out details

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    After giving exemption, NPPA asks Meril Life Sciences for MRP of its stent

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok